Log inTry free

Tiziana Life Sciences (TLSA) stock

Market cap $145M

$1.12
-1.75%

Market closed. Prices as of today's close.

Quality Score
0
Below Average
In its industry
#54of 91
Pharma
Next2026“…efforts toward na-SPMS, where the Phase 2 trial remains blinded with results expected in October this year…”Trial data · 6-K, Sep 17

Follow TLSA's trial news. Pro members can get an alert when Tiziana Life Sciences files news, and see its trials, share raises, and its CEO's filings.

Get an optional alert when TLSA files news on its trialsFree for 24 hours. No account needed.
Pipeline

What's next for TLSA

From Tiziana Life Sciences’s SEC filings and ClinicalTrials.gov: the company’s own words, the registry’s dates, and arithmetic, not a forecast. Companies often miss their own dates.

Next step the company has named

2026“change our efforts toward na-SPMS, where the Phase 2 trial remains blinded with results expected in October this year.”Trial data · 6-K, Sep 17

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway
Foralumab Nasal in Patients With Multiple System AtrophyPhase 2 · Recruiting · 5 people · main data estimated Apr 1, 2027 · NCT06868628

3 more trials, 108 filings, for Pro members.

Dilution on the horizon

  • Shelf registration (F-3, filed Mar 24, 2025)
  • At-the-market share sales program (F-3, filed Mar 24, 2025)

A shelf lets a company sell shares later; an at-the-market program sells them into the market over time. Neither is a sale by itself.

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

CEO Ivor Elrifi bought 321,423 shares on Aug 5. 3 more insider trades this year.

From their own Form 4 filings: buys and sales in the market, not awards or shares withheld for tax.

Get an optional alert when Ivor Elrifi buys or sells

For Pro members: every trade, and Ivor Elrifi’s 25 filings and quotes.

Get an optional alert when TLSA files news on its trialsFree for 24 hours. No account needed.

See every upcoming FDA date →

Biotech dates

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their own filings, soonest first and small companies first.

DateStockDrug

8 more FDA dates and 114 trial data dates in the next 60 days. Pro members see every one, with the cash against its date and an optional alert before it. Get in free →

Quality Score

Why TLSA scores 0

Below AverageTransition, 4 of 14 checks firingWhat the Quality Score means

Poor is below 0. Average starts at 6, Above Average at 11, Excellent at 15, and Exceptional at 20.

  • +4Chart checks 4 of 14 firing right now, one point each
  • −2Long-term trend below a falling 200-⁠day average, down over one year
  • Size subtracts
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Insider trades adds

No effect today: Run-up, Profit, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on TLSA and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:40 PM ET, at least 15 minutes behind. How we rank stocks.

What's next

What would turn TLSA's score around: 5 things, for Pro members

Alert me when TLSA's Quality Score turns up

Free for 24 hours. No account needed. Then keep going with a free account.

Pro

Here is what Pro members see.

Every stock has a live page like this, TLSA included: the price in real time, the full chart, all 14 checks, and every line of its score.

AMD's page for Pro members on a phone, recorded live: the price changes as it trades, beside its Quality Score and its rank, with the bid and ask under it and a year of candles below
The same page for Pro members, on AMDThe live price and the full chart, with the Quality Score drawn under it and the line that drives it.
The Score tab on a phone: how AMD's Quality Score adds up from price action, the company, and signals, its rank, and the chart checks by group, trend, volume, tight range, and buying
Every line of the scoreWhat each part adds, and all 14 checks by group, on TLSA and every other stock.
The New alert form on a phone: watch one name, AMD, when its Quality Score is at least 20, sent by the bell on the site, a push notification, and email, with the Save alert button
Your own optional alertsPick what to watch, TLSA or your whole watchlist, and when: a Quality Score, a price, a filing. It comes by push, email, or the bell.
  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.
The 14 checks

TLSA has 4 of 14 checks firing

One per group is shown here.

Trend1 of 5 shown
MA FAN21 EMAW.EMAHH/HL52W HI

Averages stacked in order, price near its high.

Volume1 of 3 shown
VOLVDUU/D VOL

Heavy volume on the run, quiet volume at rest.

Tight range1 of 3 shown
ATR SQZSQUEEZENR7

The daily range is tight against its own recent history.

Buying1 of 3 shown
OBV+CLOSE HISPRING

Closes near the high, and buyers step in on dips.

The other 10 checks on TLSA, and all 14 on every stock.Get in free →

Also on the chart

Not scored

Shown for reference. None of these counts toward the Quality Score: in our tests on 20 years of daily prices, none of them improved it.

  • RSI 1458.7

    Above 50, below 70.

  • MACD (12, 26, 9)Above signal

    Crossed above its signal line 7 sessions ago.

  • 50-day average$1.00

    The price is 12.0% above it.

  • 200-day average$1.26

    The price is 11.1% below it. The 50-day is below the 200-day, since Jan 14.

  • ADX 1418.0

    Under 25, with +DI above -DI.

  • Support$1.08

    Swing low from Jun 3, 3.6% below the price.

  • Resistance$1.15

    Swing high from Jul 31, 2.7% above the price.

  • Bollinger Bands (20, 2)Inside

    The bands run from $0.79 to $1.15.

  • Volume0.6x

    Against its 20-day average, for the time of day.

Its industry

How TLSA ranks in Pharma

TLSA is #54 of 91 by Quality Score. The top three are shown with their scores, and more by name.

More in Pharma, on the Healthcare page

Filings

Who is trading TLSA

TLSA insider trades

One insider bought $986K across 3 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyIvor Elrifi$238KChief Executive Officerat $1.00 on Aug 5, filed Aug 6
All 3 insider filings on TLSA from the last six months, for Pro members.Get in free →

An insider has two business days to file a Form 4, so the trade is already days old when it becomes public. Shown as filed, with no delay.

The company

About Tiziana Life Sciences

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

10 employeestizianalifesciences.com

Pro

Every line of the score, on every stock.

  • Real-time prices, no delay
  • Every line of TLSA's score, with the points and the reason
  • All 14 checks on TLSA and on all 3,243 stocks
  • Every stock ranked, with the chart
  • Every filing, and optional alerts on TLSA
BreakawayAug 6Ivor Elrifi bought TLSA$238K at $1.00, filed Aug 6

What a filing on TLSA would have sent. Alerts are optional.

See all 14 checks on TLSAFree for 24 hours. No account needed. Then keep going with a free account.
Questions

Straight Answers.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Where does the data come from?

Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.

Do I need an account?

Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.

Is this investment advice?

No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.